Entropy Technologies LP lifted its stake in MetLife, Inc. (NYSE:MET – Free Report) by 54.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,821 shares of the financial services provider’s stock after buying an additional 4,509 shares during the period. Entropy Technologies LP’s holdings in MetLife were worth $1,057,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of MetLife by 3.4% during the 1st quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock worth $4,418,612,000 after purchasing an additional 1,974,268 shares in the last quarter. Swedbank AB bought a new position in MetLife in the first quarter worth $131,456,000. Acadian Asset Management LLC boosted its stake in MetLife by 7,837.0% during the second quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider’s stock worth $79,250,000 after buying an additional 1,115,124 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in MetLife by 22.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after buying an additional 988,666 shares during the period. Finally, Bessemer Group Inc. raised its stake in shares of MetLife by 29.7% in the 1st quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider’s stock valued at $157,133,000 after buying an additional 485,811 shares in the last quarter. 89.81% of the stock is owned by institutional investors and hedge funds.
MetLife Stock Down 0.2 %
MetLife stock opened at $82.02 on Thursday. MetLife, Inc. has a twelve month low of $61.16 and a twelve month high of $86.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a 50 day moving average of $81.21 and a 200-day moving average of $75.38. The stock has a market capitalization of $56.79 billion, a PE ratio of 16.54, a price-to-earnings-growth ratio of 0.75 and a beta of 1.05.
MetLife Dividend Announcement
Wall Street Analysts Forecast Growth
MET has been the topic of a number of analyst reports. Piper Sandler upped their target price on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a report on Tuesday. Citigroup raised their target price on MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Wells Fargo & Company upped their price target on MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Finally, TD Cowen initiated coverage on MetLife in a report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price objective for the company. Fourteen equities research analysts have rated the stock with a buy rating, According to MarketBeat, MetLife presently has a consensus rating of “Buy” and an average price target of $88.46.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Rocket Lab is the Right Stock for the Right Time
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.